共 38 条
[1]
Gonzalez C.M., Schaeffer A.J., Treatment of urinary tract infection: What's old, what's new, and what works, World J Urol, 6, pp. 372-382, (1999)
[2]
Sobel J.D., Kaye D., Urinary tract infections, Mandell, Douglas and Bennett's. Principals and Practice of Infectious Diseases, (2000)
[3]
Schaeffer A.J., The expanding role of fluoroquinolones, Am J Med, 113, SUPPL. 1A, (2002)
[4]
Biswas D., Gupta P., Prasad R., Singh V., Arya M., Kumar A., Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance, Indian J Med Sci, 60, 2, pp. 53-58, (2006)
[5]
Goldstein F.W., Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group, Eur J Clin Microbiol Infect Dis, 19, pp. 112-117, (2000)
[6]
Gupta V., Yadav A., Joshi R.M., Antibiotic resistance pattern in uropathogen, Indian J Med Microbiol, 20, pp. 96-98, (2002)
[7]
Tankhiwale S.S., Jalgaonkar S.V., Ahamad S., Hassani U., Evaluation of extended spectrum beta lactamase in urinary isolates, Indian J Med Res, 120, pp. 553-556, (2004)
[8]
Kumar M.S., Lakshmi V., Rajagopalan R., Related Articles, Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute, Indian J Med Microbiol, 24, pp. 208-211, (2006)
[9]
Manges A.R., Natarajan P., Solberg O.D., Dietrich P.S., Riley L.W., The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: Evidence for community outbreaks of urinary tract infections, Epidemiol Infect, 134, 2, pp. 425-431, (2006)
[10]
Kahan N.R., Chinitz D.P., Waitman D.A., Dushnitzky D., Kahan E., Shapiro M., Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: Another lost treatment option?, Ann Pharmacother, 40, 12, pp. 2223-2227, (2006)